Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Morpholine → 1-[3-[7-[1-(1-Morpholin-4-yl-1-oxopropan-2-yl)pyrazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]phenyl]-3-(2,2,2-trifluoroethyl)urea
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Morpholine | HCID 8083 | — |
| 반응물 | 2-(4-{3-[3-({[(2,2,2-trifluoroethyl)amino]carbonyl}amino)phenyl]imidazo[1,2-b]pyridazin-7-yl}-1H-pyrazol-1-yl)propanoic acid | HCID 67980220 | — |
| 생성물 | 1-[3-[7-[1-(1-Morpholin-4-yl-1-oxopropan-2-yl)pyrazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]phenyl]-3-(2,2,2-trifluoroethyl)urea | HCID 57384889 | — |
반응 단계
This compound was prepared by using procedures analogous to those described for the synthesis of Example 54, Step 3 starting from 2-(4-{3-[3-({[(2,2,2-trifluoroethyl)amino]carbonyl}amino)phenyl]imidazo[1,2-b]pyridazin-7-yl}-1H-pyrazol-1-yl)propanoic acid and morpholine. LCMS (M+H)+: m/z=543.2.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08754114B2 |
| 출처 데이터셋 | uspto-grants-2014_06 |
| ORD ID | ord-040a9c9525c148b0aea3b8e86c63b2ba |
| 출처 메모 | uspto-grants-2014_06 |